Enteric Disease Testing Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Enteric Disease Testing Market Research
and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Enteric Disease Testing Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the global enteric
  disease testing market size reached US 4.2
  Billion in 2023.
• Enteric diseases are caused by the ingestion of
  food or water contaminated by microbial toxins
  and microorganisms. These microorganisms enter
  through the mouth by coming in contact with an
  infected person's feces or with animals and their
  environments, attacking the gastrointestinal
  tract.
• Enteric diseases can cause symptoms like
  diarrhea, nausea, vomiting, fever, chills,
  abdominal cramps, and a loss of appetite. In
  recent years, the approval for the
  commercialization of novel technologies and the
  launch of new products have revolutionized
  enteric disease testing.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/enteric-disease-testing
  -market/requestsample

4
Report Description

• Global Enteric Disease Testing Market Trends
• The increasing cases of enteric diseases, such as
  cholera, amebiasis, Campylobacteriosis and
  Hepatitis A, represent the primary factor that
  positively impacts the global enteric disease
  testing market. This can be attributed to the
  unhygienic conditions, unsafe drinking water and
  poor sanitation. Besides this, with the recent
  outbreak of coronavirus disease (COVID-19),
  testing for enteric diseases has increased as the
  virus is variably found in human enteric samples
  during the course of infection. As a result, many
  healthcare centers are undertaking research to
  discover the co-relation between enteric disease
  and COVID-19.
• Furthermore, as individuals are becoming more
  aware of the benefits of early diagnosis, they
  are increasingly opting for the testing of
  enteric diseases. The leading healthcare
  companies are investing in research and
  development (RD) activities to advance the
  enteric disease testing technologies to increase
  the efficiency of diagnosis. Some of the other
  factors, such as improving healthcare
  infrastructure, various technological
  advancements and the emerging trend of medical
  tourism, are expected to create a positive
  outlook for the market.
• Looking forward, the market is expected to grow
  at a CAGR of 3.1 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/enteric-disease-testing
  -market

5
Report Segmentation

• Breakup by Product Type
• Reagents and Consumables
• Equipment
•  
• Breakup by Technique
• Molecular Diagnostics
• Immunodiagnostics
• Breakup by Disease Type
• Bacterial Enteric Disease
• C. Difficile
• Campylobacteriosis
• Cholera
• E. Coli
• H. Pylori

6
Report Segmentation

• Salmonellosis
• Shigellosis
• Viral Enteric Disease
• Rotavirus
• Norovirus
• Others
• Parasitic Enteric Disease
• Amebiasis
• Cryptosporidiosis
• Giardiasis
• Breakup by End User
• Hospital Diagnostic Laboratories

7
Report Segmentation

• Independent Diagnostic Laboratories
• Academic and Research Institutes
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

8
Competitive Landscape with Key Players

• Abbott Laboratories
• BD (Becton, Dickinson and Company)
• Bio-Rad Laboratories Inc.
• Biomerica Inc.
• Biomérieux SA
• Cepheid Inc. (Danaher Corporation)
• Coris BioConcept
• DiaSorin
• Meridian Bioscience Inc.
• Quest Diagnostics.

9
Key Questions Answered in the Report
10
Key Questions Answered in the Report
11
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Enteric Disease
  Testing Market    5.1    Market Overview    5.2
     Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product Type
• 6.1 Reagents and Consumables
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Equipment
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 7 Market Breakup by Technique
• 7.1 Molecular Diagnostics
• 7.1.1 Market Trends
• 7.1.2 Market Forecast       

12
Table of Contents

• 7.2 Immunodiagnostics
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 8 Market Breakup by Disease Type
• 8.1 Bacterial Enteric Disease
• 8.1.1 Market Trends
• 8.1.2 Major Types
• 8.1.2.1 C. Difficile
• 8.1.2.2 Campylobacteriosis
• 8.1.2.3 Cholera
• 8.1.2.4 E. Coli
• 8.1.2.5 H. Pylori
• 8.1.2.6 Salmonellosis
• 8.1.2.7 Shigellosis
• 8.1.3 Market Forecast
• 8.2 Viral Enteric Disease
• 8.2.1 Market Trends
• 8.2.2 Major Types
• 8.2.2.1 Rotavirus

13
Partial List of Clients
14
Partial List of Clients
15
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

16
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us